These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3947109

  • 1. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
    Wakui A, Yokoyama M, Takahashi H, Yoshida Y, Sakata Y, Sato S, Kano A, Kawamoto K, Hashimoto S, Konno K.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):319-29. PubMed ID: 3947109
    [Abstract] [Full Text] [Related]

  • 2. [A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
    Konno K, Nagahama F, Nakai Y, Nakabayashi T, Hiraga Y, Takebe K, Tamura M, Oizumi K, Sato M, Ito T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):931-7. PubMed ID: 3008671
    [Abstract] [Full Text] [Related]

  • 3. [Phase I study of an oral administration of VP 16-213].
    Ogawa M, Ota K, Oyama A, Fukuoka M, Takada M, Yoshida S, Sanpi K, Kimura I, Ohnoshi T, Kuraishi Y.
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102
    [Abstract] [Full Text] [Related]

  • 4. [Phase I clinical study of NK 171 (etoposide)].
    Kimura K, Yamada K, Niitani H.
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):851-6. PubMed ID: 2985006
    [Abstract] [Full Text] [Related]

  • 5. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
    Konishi I, Kitani T, Nagai K, Kanamaru A, Kohsaki M, Masaoka T, Shibata H, Horiuchi A, Tsubaki K, Kawagoe H.
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
    Yoshida T, Nakanishi J, Ito K, Kobayashi S, Ohtake S, Nakamura S, Hattori K.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
    [Abstract] [Full Text] [Related]

  • 9. Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer.
    Bennett CL, Sinkule JA, Schilsky RL, Senekjian E, Choi KE.
    Cancer Res; 1987 Apr 01; 47(7):1952-6. PubMed ID: 3815383
    [Abstract] [Full Text] [Related]

  • 10. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
    Taguchi T, Niitani H, Furue H, Tsukagoshi S, Kanamaru R, Hasegawa K, Akazawa S, Yoneda S, Tominaga T, Sasaki T.
    Gan To Kagaku Ryoho; 1995 Feb 01; 22(2):259-71. PubMed ID: 7857102
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.
    Wolff I, Bench K, Beijnen JH, Bruntsch U, Cavalli F, de Jong J, Groot Y, van Tellingen O, Wanders J, Sessa C.
    Clin Cancer Res; 1996 Oct 01; 2(10):1717-23. PubMed ID: 9816122
    [Abstract] [Full Text] [Related]

  • 15. [Phase I clinical study of 21-consecutive-day oral administration of etoposide].
    Noda K, Fukuoka M, Komatsu H, Hayashihara K, Ariyoshi Y, Tanaka K, Nakajima H, Terashima Y, Nagao K, Furuse K.
    Gan To Kagaku Ryoho; 1994 Aug 01; 21(10):1633-9. PubMed ID: 8060139
    [Abstract] [Full Text] [Related]

  • 16. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
    Vaughn CB, Panettiere F, Thigpen T, Bottomley R, Hoogstraten B, Samal B.
    Cancer Treat Rep; 1981 Aug 01; 65(5-6):443-5. PubMed ID: 7237465
    [No Abstract] [Full Text] [Related]

  • 17. Phase I trial of a new form of an oral administration of VP-16-213.
    Lau ME, Hansen HH, Nissen NI, Pedersen H.
    Cancer Treat Rep; 1979 Mar 01; 63(3):485-7. PubMed ID: 371801
    [Abstract] [Full Text] [Related]

  • 18. [Phase I study of CI-898. CI-898 Study Group].
    Taguchi T, Tsukagoshi S, Furue H, Niitani H, Ohta K, Ariyoshi H, Hasegawa K, Majima H, Nakao I, Yasutomi M.
    Gan To Kagaku Ryoho; 1991 Aug 01; 18(10):1599-612. PubMed ID: 1831340
    [Abstract] [Full Text] [Related]

  • 19. [Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213].
    Joss R, Goldhirsch A, Cavalli F, Weber W, Kaplan S, Obrecht JP, Sonntag R, Brunner KW.
    Schweiz Med Wochenschr; 1981 Sep 05; 111(36):1331-4. PubMed ID: 7197802
    [Abstract] [Full Text] [Related]

  • 20. [A phase II clinical trial of oral VP 16-213 in advanced non-Hodgkin's lymphoma].
    Nakada H, Ogawa M, Ingaki J, Horikoshi N, Inoue K, Usui N, Adachi K, Tada A, Yamazaki H, Mukaiyama T.
    Gan To Kagaku Ryoho; 1984 Aug 05; 11(8):1644-8. PubMed ID: 6476837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.